Study inclusion/exclusion |
If excluded, rationale provided |
Design and setting |
|
Dates |
Study duration |
N, number of groups, and dropout rates |
|
Participant demographics |
This will include baseline cognitive status and activity or fitness level, diagnosis, disease severity, co-morbidities, Apo-E status, age, sex, nationality and/or ethnicity, socioeconomic status, and education |
Included caregiver or caretaker |
|
Recruitment approach |
|
Adherence reported according to how intervention was recorded |
For example, supervised, unsupervised, objective monitors, etc. |
Follow-up assessment |
|
Outcomes |
To include cognitive, emotional, functional, motor, physiological, social, or quality of life |
Reported challenges and conflicts |
|
Bias assessment variables |
To include randomization method, randomization concealment, blinding, method of reporting outcomes, missing information, and other relevant variables |
Outcome description |
To include scale range; minimal detectable change; and/or minimal clinically important difference; incidence of dementia; time to conversion; changes in health, cognitive, or quality of life variables; and changes in dementia related biomarkers |
Other outcome factors |
To include time to follow-up in study methodology, scale range, minimal detectable change, and/or minimal clinically important difference |
Results: included participant group sizes, summary of results |
For example, means, SD, and statistical changes |
Physical activity/exercise treatment prescription data |
Physical activity/exercise modality |
For example, type, group, peer/coach, and additional motivators |
Treatment minutes/session |
|
Treatment duration |
Total number of weeks |
Supervised or unsupervised treatment paradigm |
|
Harm or side effects |
Drug or secondary health condition interaction |